Company Filing History:
Years Active: 2020
Title: Sirkka Kyostio-Moore: Innovator in Gene Therapy
Introduction
Sirkka Kyostio-Moore is a notable inventor based in Ashland, MA (US). She has made significant contributions to the field of gene therapy, particularly in the production of adeno-associated virus (AAV) particles. Her innovative work has implications for various therapeutic applications.
Latest Patents
Sirkka holds a patent for the "Production of oversized adeno-associated vectors." This patent outlines methods for producing AAV particles that contain oversized recombinant AAV genomes, specifically those greater than 4.7 kb. The invention also provides AAV particles and vectors that comprise these oversized genomes, along with producer cell lines designed to produce AAV particles containing oversized genomes.
Career Highlights
Sirkka is currently associated with Genzyme Corporation, a leading biotechnology company. Her work at Genzyme has allowed her to focus on advancing gene therapy technologies and improving treatment options for patients.
Collaborations
Sirkka collaborates with talented professionals in her field, including David Souza and Karen Vincent. Their combined expertise contributes to the success of their projects and innovations.
Conclusion
Sirkka Kyostio-Moore's contributions to the field of gene therapy through her patent and work at Genzyme Corporation highlight her role as an influential inventor. Her innovative methods for producing AAV particles pave the way for future advancements in therapeutic applications.